345 related articles for article (PubMed ID: 27720688)
1. Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models.
Houben RMGJ; Menzies NA; Sumner T; Huynh GH; Arinaminpathy N; Goldhaber-Fiebert JD; Lin HH; Wu CY; Mandal S; Pandey S; Suen SC; Bendavid E; Azman AS; Dowdy DW; Bacaër N; Rhines AS; Feldman MW; Handel A; Whalen CC; Chang ST; Wagner BG; Eckhoff PA; Trauer JM; Denholm JT; McBryde ES; Cohen T; Salomon JA; Pretorius C; Lalli M; Eaton JW; Boccia D; Hosseini M; Gomez GB; Sahu S; Daniels C; Ditiu L; Chin DP; Wang L; Chadha VK; Rade K; Dewan P; Hippner P; Charalambous S; Grant AD; Churchyard G; Pillay Y; Mametja LD; Kimerling ME; Vassall A; White RG
Lancet Glob Health; 2016 Nov; 4(11):e806-e815. PubMed ID: 27720688
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models.
Menzies NA; Gomez GB; Bozzani F; Chatterjee S; Foster N; Baena IG; Laurence YV; Qiang S; Siroka A; Sweeney S; Verguet S; Arinaminpathy N; Azman AS; Bendavid E; Chang ST; Cohen T; Denholm JT; Dowdy DW; Eckhoff PA; Goldhaber-Fiebert JD; Handel A; Huynh GH; Lalli M; Lin HH; Mandal S; McBryde ES; Pandey S; Salomon JA; Suen SC; Sumner T; Trauer JM; Wagner BG; Whalen CC; Wu CY; Boccia D; Chadha VK; Charalambous S; Chin DP; Churchyard G; Daniels C; Dewan P; Ditiu L; Eaton JW; Grant AD; Hippner P; Hosseini M; Mametja D; Pretorius C; Pillay Y; Rade K; Sahu S; Wang L; Houben RMGJ; Kimerling ME; White RG; Vassall A
Lancet Glob Health; 2016 Nov; 4(11):e816-e826. PubMed ID: 27720689
[TBL] [Abstract][Full Text] [Related]
3. Tuberculosis control interventions targeted to previously treated people in a high-incidence setting: a modelling study.
Marx FM; Yaesoubi R; Menzies NA; Salomon JA; Bilinski A; Beyers N; Cohen T
Lancet Glob Health; 2018 Apr; 6(4):e426-e435. PubMed ID: 29472018
[TBL] [Abstract][Full Text] [Related]
4. Tuberculosis prevention in South Africa.
Knight GM; Dodd PJ; Grant AD; Fielding KL; Churchyard GJ; White RG
PLoS One; 2015; 10(4):e0122514. PubMed ID: 25849558
[TBL] [Abstract][Full Text] [Related]
5. Application of provincial data in mathematical modelling to inform sub-national tuberculosis program decision-making in South Africa.
Hippner P; Sumner T; Houben RM; Cardenas V; Vassall A; Bozzani F; Mudzengi D; Mvusi L; Churchyard G; White RG
PLoS One; 2019; 14(1):e0209320. PubMed ID: 30682028
[TBL] [Abstract][Full Text] [Related]
6. Strategies for ending tuberculosis in the South-East Asian Region: A modelling approach.
Arinaminpathy N; Mandal S; Bhatia V; McLeod R; Sharma M; Swaminathan S; Hyder KA; Mandal PP; Sarkar SK; Singh PK
Indian J Med Res; 2019 Apr; 149(4):517-527. PubMed ID: 31411176
[TBL] [Abstract][Full Text] [Related]
7. Tuberculosis control strategies to reach the 2035 global targets in China: the role of changing demographics and reactivation disease.
Huynh GH; Klein DJ; Chin DP; Wagner BG; Eckhoff PA; Liu R; Wang L
BMC Med; 2015 Apr; 13():88. PubMed ID: 25896465
[TBL] [Abstract][Full Text] [Related]
8. Projected population-wide impact of antiretroviral therapy-linked isoniazid preventive therapy in a high-burden setting.
Kendall EA; Azman AS; Maartens G; Boulle A; Wilkinson RJ; Dowdy DW; Rangaka MX
AIDS; 2019 Mar; 33(3):525-536. PubMed ID: 30325773
[TBL] [Abstract][Full Text] [Related]
9. The potential effects of changing HIV treatment policy on tuberculosis outcomes in South Africa: results from three tuberculosis-HIV transmission models.
Pretorius C; Menzies NA; Chindelevitch L; Cohen T; Cori A; Eaton JW; Fraser C; Gopalappa C; Hallett TB; Salomon JA; Stover J; White RG; Dodd PJ
AIDS; 2014 Jan; 28 Suppl 1():S25-34. PubMed ID: 24468944
[TBL] [Abstract][Full Text] [Related]
10. Effect of improved tuberculosis screening and isoniazid preventive therapy on incidence of tuberculosis and death in patients with HIV in clinics in Rio de Janeiro, Brazil: a stepped wedge, cluster-randomised trial.
Durovni B; Saraceni V; Moulton LH; Pacheco AG; Cavalcante SC; King BS; Cohn S; Efron A; Chaisson RE; Golub JE
Lancet Infect Dis; 2013 Oct; 13(10):852-8. PubMed ID: 23954450
[TBL] [Abstract][Full Text] [Related]
11. Tuberculosis control in South African gold mines: mathematical modeling of a trial of community-wide isoniazid preventive therapy.
Vynnycky E; Sumner T; Fielding KL; Lewis JJ; Cox AP; Hayes RJ; Corbett EL; Churchyard GJ; Grant AD; White RG
Am J Epidemiol; 2015 Apr; 181(8):619-32. PubMed ID: 25792607
[TBL] [Abstract][Full Text] [Related]
12. Evaluating the potential impact of enhancing HIV treatment and tuberculosis control programmes on the burden of tuberculosis.
Chindelevitch L; Menzies NA; Pretorius C; Stover J; Salomon JA; Cohen T
J R Soc Interface; 2015 May; 12(106):. PubMed ID: 25878131
[TBL] [Abstract][Full Text] [Related]
13. Effect of different interventions for latent tuberculosis infections in China: a model-based study.
Wen Z; Li T; Zhu W; Chen W; Zhang H; Wang W
BMC Infect Dis; 2022 May; 22(1):488. PubMed ID: 35606696
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of post-treatment follow-up examinations and secondary prevention of tuberculosis in a high-incidence setting: a model-based analysis.
Marx FM; Cohen T; Menzies NA; Salomon JA; Theron G; Yaesoubi R
Lancet Glob Health; 2020 Sep; 8(9):e1223-e1233. PubMed ID: 32827484
[TBL] [Abstract][Full Text] [Related]
15. The impact of HIV and tuberculosis interventions on South African adult tuberculosis trends, 1990-2019: a mathematical modeling analysis.
Kubjane M; Osman M; Boulle A; Johnson LF
Int J Infect Dis; 2022 Sep; 122():811-819. PubMed ID: 35872098
[TBL] [Abstract][Full Text] [Related]
16. [Tuberculosis in Asia].
Kekkaku; 2002 Oct; 77(10):693-7. PubMed ID: 12440145
[TBL] [Abstract][Full Text] [Related]
17. Modelling the economic benefits of tuberculosis preventive therapy for people with HIV: the example of Zambia.
Foster S; Godfrey-Faussett P; Porter J
AIDS; 1997 Jun; 11(7):919-25. PubMed ID: 9189218
[TBL] [Abstract][Full Text] [Related]
18. Catastrophic costs potentially averted by tuberculosis control in India and South Africa: a modelling study.
Verguet S; Riumallo-Herl C; Gomez GB; Menzies NA; Houben RMGJ; Sumner T; Lalli M; White RG; Salomon JA; Cohen T; Foster N; Chatterjee S; Sweeney S; Baena IG; Lönnroth K; Weil DE; Vassall A
Lancet Glob Health; 2017 Nov; 5(11):e1123-e1132. PubMed ID: 29025634
[TBL] [Abstract][Full Text] [Related]
19. The potential impact of preventive therapy against tuberculosis in the WHO South-East Asian Region: a modelling approach.
Mandal S; Bhatia V; Sharma M; Mandal PP; Arinaminpathy N
BMC Med; 2020 Jul; 18(1):163. PubMed ID: 32684164
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
